• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JCV 尿病毒血症与活体肾捐献 3 年后肾功能恢复不佳相关。

JCV viruria associates with suboptimal recovery of kidney function three years after living kidney donation.

机构信息

Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Unidade de Transplantação Renal, Serviço de Nefrologia, Carnaxide, Portugal.

Hospital do Divino Espírito Santo, Serviço de Nefrologia, Ponta Delgada, Portugal.

出版信息

J Bras Nefrol. 2022 Jul-Sep;44(3):368-375. doi: 10.1590/2175-8239-JBN-2021-0148.

DOI:10.1590/2175-8239-JBN-2021-0148
PMID:35138324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9518630/
Abstract

INTRODUCTION

Few studies have investigated pre-donation factors that could affect renal recovery after living kidney donation (LKD). We retrospectively investigated the role of John Cunningham virus (JCV) infection and other pre-donation factors on the magnitude of kidney function decline after LKD.

METHODS

Urine JCV viral loads, glomerular filtration rate, and blood pressure were evaluated in 60 consecutive LK donors before donation. Suboptimal compensatory hypertrophy was defined as an eGFR <60% of the pre-donation eGFR.

RESULTS

LKD (40% JCV infected) were followed for 3.2±1.6 years. No association was found between age, gender, and baseline hypertension with 1st, 2nd, 3rd, and 4th years post-donation eGFR <60% of the pre-donation eGFR. Mean eGFR recovery at the 3rd year after donation was lower in JCV infected donors vs non-infected donors (61.8% vs 71.0%, p=0.006).

CONCLUSION

We hypothesized that JCV could shift glomeruli into a hyperfiltration state before nephrectomy, modulating the magnitude of compensatory hypertrophy after donation. Conversely, JCV might curtail the ability of the remaining kidney to promote hyperfiltration. Longer follow up is needed to determine whether JCV viruria ultimately leads to lower eGFR over time or if it is a protective factor for the remaining kidney.

摘要

简介

鲜有研究调查过活体供肾(LKD)后影响肾脏恢复的术前因素。我们回顾性研究了 JC 病毒(JCV)感染和其他术前因素对 LKD 后肾功能下降幅度的影响。

方法

在 60 例连续的 LKD 供者术前评估了尿液 JCV 病毒载量、肾小球滤过率和血压。定义肾小球代偿性肥大不足为 eGFR<术前 eGFR 的 60%。

结果

对 LKD(40% JCV 感染)供者随访 3.2±1.6 年。年龄、性别和基线高血压与第 1、2、3 和 4 年 eGFR<术前 eGFR 的 60%均无相关性。与未感染供者相比,JCV 感染供者在术后第 3 年 eGFR 恢复均值较低(61.8%vs71.0%,p=0.006)。

结论

我们推测 JCV 可能在肾切除术前使肾小球进入高滤过状态,从而调节供肾后代偿性肥大的幅度。相反,JCV 可能会削弱剩余肾脏促进高滤过的能力。需要更长时间的随访来确定 JCV 尿病毒载量是否最终导致 eGFR 随时间下降,还是剩余肾脏的保护因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/9518630/13d09bfe32fe/2175-8239-jbn-2021-0148-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/9518630/13d09bfe32fe/2175-8239-jbn-2021-0148-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/9518630/13d09bfe32fe/2175-8239-jbn-2021-0148-gf01.jpg

相似文献

1
JCV viruria associates with suboptimal recovery of kidney function three years after living kidney donation.JCV 尿病毒血症与活体肾捐献 3 年后肾功能恢复不佳相关。
J Bras Nefrol. 2022 Jul-Sep;44(3):368-375. doi: 10.1590/2175-8239-JBN-2021-0148.
2
Outcomes of Living Kidney Donor Candidates and Living Kidney Recipient Candidates with JC Polyomavirus and BK Polyomavirus Viruria.携带JC多瘤病毒和BK多瘤病毒病毒尿症的活体肾供体候选者及活体肾受体候选者的结局
Int J Nephrol. 2021 Aug 19;2021:8010144. doi: 10.1155/2021/8010144. eCollection 2021.
3
Factors related to suboptimal recovery of renal function after living donor nephrectomy: a retrospective study.活体供肾肾切除术后肾功能恢复不佳的相关因素:一项回顾性研究。
BMC Nephrol. 2019 Nov 8;20(1):403. doi: 10.1186/s12882-019-1588-3.
4
Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.60岁以上肾脏供体的结局:一项单中心队列研究。
World J Surg. 2017 Nov;41(11):2940-2948. doi: 10.1007/s00268-017-4071-y.
5
Insufficient early renal recovery and progression to subsequent chronic kidney disease in living kidney donors.活体供肾者早期肾功能恢复不足及随后进展为慢性肾脏病。
Korean J Intern Med. 2022 Sep;37(5):1021-1030. doi: 10.3904/kjim.2021.308. Epub 2022 Apr 13.
6
Prediction model of compensation for contralateral kidney after living-donor donation.活体供肾捐献后对侧肾脏代偿预测模型。
BMC Nephrol. 2019 Jul 26;20(1):283. doi: 10.1186/s12882-019-1464-1.
7
Predictors of Outcomes of Living Kidney Donation: Impact of Sex, Age and Preexistent Hypertension.活体肾移植供者预后的预测因素:性别、年龄及既往高血压的影响
Transplant Proc. 2019 Mar;51(2):396-404. doi: 10.1016/j.transproceed.2019.01.015. Epub 2019 Jan 4.
8
Predictors of low estimated glomerular filtration rate after living kidney donation in a Southeast Asian population from Singapore.新加坡东南亚人群活体肾移植后低估算肾小球滤过率的预测因素
Nephrology (Carlton). 2017 Oct;22(10):761-768. doi: 10.1111/nep.12845.
9
Predictive factors of glomerular filtration rate loss associated with living kidney donation: a single-center retrospective study.与活体肾脏捐献相关的肾小球滤过率损失的预测因素:一项单中心回顾性研究。
World J Urol. 2022 Sep;40(9):2161-2168. doi: 10.1007/s00345-022-04019-x. Epub 2022 May 20.
10
Association between pre-donation serum uric acid concentration and change in renal function after living kidney donation in women.女性活体肾捐献前血清尿酸浓度与肾捐献后肾功能变化之间的关联。
Intern Med J. 2014 Dec;44(12a):1217-22. doi: 10.1111/imj.12591.

本文引用的文献

1
Prevalence, Mechanisms, Treatment, and Complications of Hypertension Postliving Kidney Donation.活体肾移植后高血压的患病率、机制、治疗和并发症。
Biomed Res Int. 2021 Feb 4;2021:5460672. doi: 10.1155/2021/5460672. eCollection 2021.
2
The kidney evaluation of living kidney donor candidates: US practices in 2017.活体供肾者候选人的肾脏评估:2017 年美国的实践。
Am J Transplant. 2020 Dec;20(12):3379-3389. doi: 10.1111/ajt.15951. Epub 2020 May 22.
3
Prediction model of compensation for contralateral kidney after living-donor donation.
活体供肾捐献后对侧肾脏代偿预测模型。
BMC Nephrol. 2019 Jul 26;20(1):283. doi: 10.1186/s12882-019-1464-1.
4
JC Virus and Risk Alleles in Black South Africans With Hypertension-Attributed CKD.南非黑人高血压相关性慢性肾脏病患者中的JC病毒与风险等位基因
Kidney Int Rep. 2019 May 17;4(7):939-945. doi: 10.1016/j.ekir.2019.05.006. eCollection 2019 Jul.
5
JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease.JC 病毒尿症与降低糖尿病肾病风险相关。
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2286-2294. doi: 10.1210/jc.2018-02482.
6
Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.活体肾移植后早期高血压和糖尿病:一项全国队列研究。
Transplantation. 2019 Jun;103(6):1216-1223. doi: 10.1097/TP.0000000000002411.
7
SGLT2 inhibition and kidney protection.SGLT2 抑制剂与肾脏保护。
Clin Sci (Lond). 2018 Jun 28;132(12):1329-1339. doi: 10.1042/CS20171298. Print 2018 Jun 29.
8
Estimated glomerular filtration rate for longitudinal follow-up of living kidney donors.用于活体肾脏捐献者纵向随访的估计肾小球滤过率。
Nephrol Dial Transplant. 2018 Jun 1;33(6):1054-1064. doi: 10.1093/ndt/gfx370.
9
JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans.JC 多瘤病毒尿症与非裔美国人慢性肾脏病的保护相关,与载脂蛋白 L1 基因型无关。
Nephrol Dial Transplant. 2018 Nov 1;33(11):1960-1967. doi: 10.1093/ndt/gfx368.
10
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.《肾脏疾病:改善全球预后(KDIGO)活体肾捐献者评估与管理临床实践指南》总结
Transplantation. 2017 Aug;101(8):1783-1792. doi: 10.1097/TP.0000000000001770.